RPM Declares Quarterly Dividend
MEDINA, Ohio–(BUSINESS WIRE)–RPM International Inc. (NYSE: RPM) today announced that its board of directors declared a regular quarterly cash dividend... Read more.
RPM Declares Quarterly Dividend
MEDINA, Ohio–(BUSINESS WIRE)–RPM International Inc. (NYSE: RPM) today announced that its board of directors declared a regular quarterly cash dividend... Read more.
BWXT Names Nicole W. Piasecki to Board of Directors
LYNCHBURG, Va.–(BUSINESS WIRE)–$BWXT–BWX Technologies, Inc. (NYSE: BWXT) announced today that Nicole W. Piasecki has been appointed to its board... Read more.
Harvey J. Berger, M.D. Joins Kojin Therapeutics as Chairman, President, and Chief Executive Officer
Biotech-industry pioneer and ARIAD founder to lead company’s efforts to develop a new class of therapies targeting ferroptosis BOSTON–(BUSINESS WIRE)–Kojin... Read more.
Merck to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M.... Read more.
NOV Announces Fourth Quarter and Full Year 2023 Earnings Conference Call
HOUSTON–(BUSINESS WIRE)–NOV Inc. (NYSE: NOV) will hold a conference call to discuss its fourth quarter and full year 2023 results on Friday, February... Read more.
TDCX Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Remaining Outstanding Class A Ordinary Shares of the Company
SINGAPORE–(BUSINESS WIRE)–TDCX Inc. (“TDCX” or the “Company”) (NYSE: TDCX), today announced that its board of directors (the “Board”) has... Read more.
The Walt Disney Company and ValueAct Capital Enter Into Information-sharing Arrangement to Facilitate Strategic Consultation During Company’s Transformation
Investment Firm Will Support the Disney Board’s Slate of Director Nominees at 2024 Annual Meeting BURBANK, Calif. & SAN FRANCISCO–(BUSINESS WIRE)–The... Read more.
Alzheon CEO Dr. Martin Tolar to Present ALZ-801/Valiltramiprosate Investigational Oral Alzheimer’s Treatment Program at Nobel Forum at Karolinska Institute in Stockholm, Sweden
Fully Enrolled Pivotal APOLLOE4 Phase 3 Trial in Early Alzheimer’s Patients on Track for Topline Data Readout and Initiation of NDA Submission in 2024 ALZ-801... Read more.
Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology Summit
HENDERSON, Nev.–(BUSINESS WIRE)–$ZURA #TeamZura—Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio”), a multi-asset clinical-stage biotechnology company... Read more.